Skip to main content

Advertisement

Log in

PinX1 inhibits cell proliferation, migration and invasion in glioma cells

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

PinX1 induces apoptosis and suppresses cell proliferation in some cancer cells, and the expression of PinX1 is frequently decreased in some cancer and negatively associated with metastasis and prognosis. However, the precise roles of PinX1 in gliomas have not been studied. In this study, we found that PinX1 obviously reduced the gliomas cell proliferation through regulating the expressions of cell cycle-relative molecules to arrest cell at G1 phase and down-regulating the expression of component telomerase reverse transcriptase (hTERT in human), which is the hardcore of telomerase. Moreover, PinX1 could suppress the abilities of gliomas cell wound healing, migration and invasion via suppressing MMP-2 expression and increasing TIMP-2 expression. In conclusion, our results suggested that PinX1 may be a potential suppressive gene in the progression of gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ostrom QT, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(Suppl 2):1–56.

    Article  Google Scholar 

  2. Goodenberger ML. RB Jenkins. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.

    Article  CAS  PubMed  Google Scholar 

  3. Urbanska K, et al. Glioblastoma multiforme - an overview. Contemp Oncol (Pozn). 2014;18(5):307–12.

    PubMed Central  PubMed  Google Scholar 

  4. Mrugala MM. Advances and challenges in the treatment of glioblastoma: a clinician’s perspective. Discov Med. 2013;15(83):221–30.

    PubMed  Google Scholar 

  5. Sorensen AG, et al. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 2012;72(2):402–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Specenier P. Bevacizumab in glioblastoma multiforme. Expert Rev Anticancer Ther. 2012;12(1):9–18.

    Article  CAS  PubMed  Google Scholar 

  7. Karcher S, et al. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer. 2006;118(9):2182–9.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou XZ, Lu KP. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 2001;107(3):347–59.

    Article  CAS  PubMed  Google Scholar 

  9. Yoo JE, Park YN, Oh BK. PinX1, a telomere repeat-binding factor 1 (TRF1)-interacting protein, maintains telomere integrity by modulating TRF1 homeostasis, the process in which human telomerase reverse Transcriptase (hTERT) plays dual roles. J Biol Chem. 2014;289(10):6886–98.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Yonekawa T, Yang S, Counter CM. PinX1 localizes to telomeres and stabilizes TRF1 at mitosis. Mol Cell Biol. 2012;32(8):1387–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Zhou XZ, et al. The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice. J Clin Invest. 2011;121(4):1266–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Kondo T, et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene. 2005;24(1):157–64.

    Article  CAS  PubMed  Google Scholar 

  13. Ma Y, et al. The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin Oncol. 2009;135(3):431–7.

    Article  CAS  PubMed  Google Scholar 

  14. Shi R, et al. Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer. Cancer Cell Int. 2014;14:46.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Cai MY, et al. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010;101(6):1543–9.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang R, et al. PinX1 without the G-patch motif suppresses proliferation, induces senescence, but does not inhibit telomerase activity in colorectal cancer SW480 cells. Oncol Rep. 2014;32(1):286–92.

    CAS  PubMed  Google Scholar 

  17. Liu JY, et al. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway. Mol Cancer. 2013;12(1):148.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Bai J, et al. JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling. Oncogene. 2010;29(8):1227–37.

    Article  CAS  PubMed  Google Scholar 

  19. Denicourt C, Dowdy SF. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 2004;18(8):851–5.

    Article  CAS  PubMed  Google Scholar 

  20. Zuo J, et al. Expression and mechanism of PinX1 and telomerase activity in the carcinogenesis of esophageal epithelial cells. Oncol Rep. 2013;30(4):1823–31.

    CAS  PubMed  Google Scholar 

  21. Chaudhary AK, et al. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview. Mutat Res. 2013;753(1):7–23.

    Article  CAS  PubMed  Google Scholar 

  22. Libra M, et al. Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int J Oncol. 2009;34(4):897–903.

    Article  CAS  PubMed  Google Scholar 

  23. Wan SM, et al. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression. J Clin Pathol. 2011;64(12):1051–7.

    Article  CAS  PubMed  Google Scholar 

  24. Collins K. The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol. 2006;7(7):484–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Zhang B, et al. Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation. Oncogene. 2012;31(1):1–12.

    Article  PubMed  Google Scholar 

  26. Nakada M, et al. Molecular targets of glioma invasion. Cell Mol Life Sci. 2007;64(4):458–78.

    Article  CAS  PubMed  Google Scholar 

  27. Cuddapah VA, et al. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15(7):455–65.

    Article  CAS  PubMed  Google Scholar 

  28. Nie E, et al. beta-Catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition. Biochem Biophys Res Commun. 2014.

  29. Roomi MW, et al. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines. Int J Oncol. 2014;45(2):887–94.

    CAS  PubMed  Google Scholar 

  30. Singh MK, et al. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin alphav and TGF-beta1 expressions. Tumour Biol. 2014;35(3):2231–46.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project is supported by grants from the National Natural Science Foundation of China (Nos. 81472663, 81201636), the Science and Technology Department of Jiangsu Province (No. BK2012139) and China Postdoctoral Science Foundation (No. 2014T70549, 2012M511323).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jin Bai or Jun-Nian Zheng.

Additional information

Peng-Jin Mei and Yan-Su Chen contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mei, PJ., Chen, YS., Du, Y. et al. PinX1 inhibits cell proliferation, migration and invasion in glioma cells. Med Oncol 32, 73 (2015). https://doi.org/10.1007/s12032-015-0545-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-015-0545-7

Keywords

Navigation